Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy As First-Line Treatment in Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
Latest Information Update: 29 Dec 2020
At a glance
- Drugs Pegaspargase (Primary) ; Sintilimab (Primary)
- Indications Extranodal NK-T-cell lymphoma
- Focus Therapeutic Use
- Acronyms SPENT
- 29 Dec 2020 New trial record